Search Results

Showing results 71 - 80 of 2117.
Sort By: Date ▼

Is the US wasting donated kidneys? New study sparks debate.

September 5, 2019


There are 93,000 people in the United States waiting for a kidney transplant, and kidney disease kills about 5,000 U.S. residents on the kidney waiting list annually—yet a study published last week in JAMA Internal Medicine estimated the United States throws away at least 3,500 donated kidneys every year.

Medicare paid twice for about $161M in hospice drugs, report finds

September 5, 2019


Medicare Part D in 2016 unnecessarily spent an estimated $161 million on drugs that already were covered under Medicare Part A, according to an HHS Office of Inspector General report released last week.

Trump admin ends 'deferred action' policy for undocumented immigrants undergoing life-saving medical care

September 3, 2019


U.S. Citizenship and Immigration Services earlier this month quietly eliminated a policy that allowed undocumented immigrants to avoid deportation while they or their family members are receiving life-saving medical care—though the agency yesterday said it is reviewing whether to continue "a very limited" version of the policy.

Hurricane Dorian could hit the US today. Here's how hospitals are preparing.

September 3, 2019


As Hurricane Dorian approaches the United States, hospitals up the Atlantic coast are preparing for the powerful storm.

Medicare Part D spending on MS drugs increased tenfold as prices spiked, study suggests

September 3, 2019


Rising prices for multiple sclerosis drugs drove a more than sevenfold increase in out-of-pocket costs for Medicare Part D beneficiaries over a decade, according to a study published last week in JAMA Neurology.

One family's $6M drug claim (and what it means for the future of rare diseases)

August 28, 2019


Dawn Patterson and two of her children have a rare bone disease, and the only treatment is a drug that was slated to cost $6 million a year—a high price tag that observers say is indicative of the pharmaceutical industry's growing interest in treatment for rare diseases.

A controversy erupts: Should we give up hope on biosimilars?

August 28, 2019


Two experts in a Wall Street Journal opinion piece published last week argued that it is time to abandon biosimilars in favor of leveraging federal price regulation to create more affordable biologic drugs—but the piece drew a rebuttal from former FDA Commissioner Scott Gottlieb, who argued Congress could enact policy changes to make biosmilars more competitive with their biologic counterparts.

Here's Florida's plan to import drugs from Canada

August 27, 2019


Florida's Agency for Health Care Administration on Wednesday submitted a concept paper to HHS outlining the state's proposal for importing drugs from Canada.

Trump's latest push to address veteran suicides? This black-boxed antidepressant.

August 27, 2019


President Trump on Wednesday said he had directed Veterans Affairs to purchase a large amount of Johnson & Johnson's ketamine-based antidepressant, which FDA has mandated must be sold with a so-called "black box" warning, in hopes of reducing veteran suicides—but VA in a statement indicated that its policy for covering the drug remained unchanged.

The 16 health care companies 'changing the world,' according to Fortune

August 26, 2019


Fortune last week released its fifth annual Change the World list, which recognizes for-profit companies that are "doing well by doing good," and 16 health care companies made the list.

Results Page: [Previous] ... 6 7 8 9 10  ... [Next]